Brief: Daré Bioscience Reports Q3 Loss Of $0.08 Per Share
Nov 10 (Reuters) - Dare Bioscience Inc DARE.O :
* DARÉ BIOSCIENCE REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES A COMPANY UPDATE
* QTRLY LOSS PER SHARE $0.08
* Q3 EARNINGS PER SHARE VIEW $-0.12 -- REFINITIV IBES DATA
* DARE-HRT1: POSITIVE TOPLINE EFFICACY DATA FROM PHASE 1/2
CLINICAL STUDY
Source text for Eikon: ID:nGNXbqW1Ys
Further company coverage: DARE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dare Bioscience
See all newsBrief: Dare Bioscience - Files For Resale Of Up To 8,934,345 Shares Of Common Stock - SEC Filing
Brief: Daré Bioscience CEO Sabrina Martucci Johnson Named To Forbes 2026 “50 Over 50 Innovation” List
NASDAQ RESUMED AT 12:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:45 PM
Dare Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary